Literature DB >> 15583035

A maternal blood-borne factor promotes survival of the developing thalamus.

Peter Landgraf1, Frank Sieg, Petra Wahle, Gundela Meyer, Michael R Kreutz, Hans-Christian Pape.   

Abstract

In this report, we describe the identification of a polypeptide survival-promoting factor that is produced by maternal and early postnatal peripheral blood mononuclear cells (PBMCs) of the immune system in Long-Evans rats and humans. The factor, termed Y-P30, most likely arises from proteolytic processing of a larger precursor protein and accumulates mainly in pyramidal neurons of the developing cortex and hippocampus but not in astrocytes. It was released from neurons grown in culture and substantially promotes survival of cells in explant monocultures of perinatal thalamus from the offspring. Y-P30 mRNA was not detectable in infant or adult brain and was present only in blood cells of pregnant rats and humans but not in nonpregnant controls. However, Y-P30 transcription could be induced in PBMCs of adult animals by a central nervous system lesion (i.e., optic nerve crush), which points to a potential role of the factor not only in neuronal development but also in neuroinflammation after white matter injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15583035     DOI: 10.1096/fj.04-1789fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  9 in total

1.  Anti-inflammatory peptide regulates the supply of heat shock protein 70 monomers: implications for aging and age-related disease.

Authors:  Timothy J Cunningham; Jeffrey I Greenstein; Joshua Loewenstern; Elias Degermentzidis; Lihua Yao
Journal:  Rejuvenation Res       Date:  2015-04       Impact factor: 4.663

2.  The survival-promoting peptide Y-P30 enhances binding of pleiotrophin to syndecan-2 and -3 and supports its neuritogenic activity.

Authors:  Peter Landgraf; Petra Wahle; Hans-Christian Pape; Eckart D Gundelfinger; Michael R Kreutz
Journal:  J Biol Chem       Date:  2008-07-03       Impact factor: 5.157

Review 3.  Antimicrobial peptides in human skin disease.

Authors:  Kenshi Yamasaki; Richard L Gallo
Journal:  Eur J Dermatol       Date:  2007-12-18       Impact factor: 3.328

4.  Inhibition of secreted phospholipase A2 by neuron survival and anti-inflammatory peptide CHEC-9.

Authors:  Timothy J Cunningham; Jaquie Maciejewski; Lihua Yao
Journal:  J Neuroinflammation       Date:  2006-09-11       Impact factor: 8.322

5.  The primate-specific peptide Y-P30 regulates morphological maturation of neocortical dendritic spines.

Authors:  Janine R Neumann; Suvarna Dash-Wagh; Alexander Jack; Andrea Räk; Kay Jüngling; Mohammad I K Hamad; Hans-Christian Pape; Michael R Kreutz; Martin Puskarjov; Petra Wahle
Journal:  PLoS One       Date:  2019-02-13       Impact factor: 3.240

6.  Reply: Expression of the proteolysis-inducing factor core-peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastrooesophageal malignancy.

Authors:  D A C Deans; S J Wigmore; H Gilmour; M J Tisdale; K C H Fearon; J A Ross
Journal:  Br J Cancer       Date:  2007-12-18       Impact factor: 7.640

7.  Binding of Y-P30 to syndecan 2/3 regulates the nuclear localization of CASK.

Authors:  Peter Landgraf; Marina Mikhaylova; Tamar Macharadze; Corinna Borutzki; Ana-Claudia Zenclussen; Petra Wahle; Michael R Kreutz
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

8.  Analysis of Y-P30/Dermcidin expression and properties of the Y-P30 peptide.

Authors:  Marina Mikhaylova; Anne Schumacher; Corinna Borutzki; Janine R Neumann; Tamar Macharadze; Tarek El-Mousleh; Petra Wahle; Ana C Zenclussen; Michael R Kreutz
Journal:  BMC Res Notes       Date:  2014-06-26

9.  Molecular Dissection of Cyclosporin A's Neuroprotective Effect Reveals Potential Therapeutics for Ischemic Brain Injury.

Authors:  Minoru Kawakami
Journal:  Brain Sci       Date:  2013-09-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.